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Type XIII collagen is a short chain collagen which has
recently been shown to be a transmembrane protein.
The purpose of this study was to elucidate the presence
and localization of type XIII collagen in normal human
skin and cultured keratinocytes. Expression of type XIII
collagen was demonstrated in normal human skin and
epidermis at the RNA level using reverse transcription
followed by polymerase chain reaction and at the pro-
tein level using western blotting and indirect immuno-
fluorescence labeling. Immunolabeling of epidermis
revealed type XIII collagen both in the cell–cell contact
sites and in the dermal–epidermal junction. In cultured
keratinocytes type XIII collagen epitopes were detected
Specific junctions of keratinocytes are essential for theintegrity and the protective barrier function of theepidermis, and may also take part in signal transductionbetween cells (Garrod et al, 1996). Desmosomes mediatecell–cell interactions between keratinocytes, and hemi-
desmosomes mediate cell–matrix interactions by forming adhesion
sites between basal keratinocytes and the dermal–epidermal base-
ment membrane (for reviews see Garrod, 1993; Burge, 1994;
Borradori and Sonnenberg, 1996; Garrod et al, 1996; Burgeson
and Christiano, 1997). Both desmosomes and hemidesmosomes
have electron-dense cell membrane-associated plaques which are
linked intracellularly to cytokeratin-containing intermediate fila-
ments and extracellularly to desmosomal transmembrane proteins
on neighboring cell surface, or to the dermal–epidermal basement
membrane. The molecular components of desmosomes and hemi-
desmosomes are quite different. For instance, desmosomes charac-
teristically contain desmoplakins, desmogleins, and desmocollins
whereas hemidesmosomes consist, e.g., BP230 (BPAG1), plectin
α6β4 integrin and BP180 (BPAG2, type XVII collagen) (Garrod,
1993; Borradori and Sonnenberg, 1996; Green and Jones, 1996).
The adherens junctions represent another type of cell–cell
contacts of the epidermis. These junctions are characterized with
parallel arrangement of plasma membranes of adjacent keratinocytes,
and an attachment plaque which is, however, markedly less electron
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in focalcontactsandin intercellularcontacts.Theresults
of this study show very little colocalization of type XIII
collagen and desmosomal components at the light
microscopic level. Thus, these results suggest that type
XIII collagen is unlikely to be a component of desmo-
somes. Instead, the punctate labeling pattern of type
XIII collagen at the cell–cell contact sites and high
degree of colocalization with E-cadherin suggests that
type XIII collagen is very likely to be closely associated
with adherens type junctions, and may, in fact, be a
component of these junctions. Key words: cell adhesion/
cell–cell interaction/dermal–epidermal junction/focal contact.
J Invest Dermatol 113:635–642, 1999
dense than that of desmosomes (Haftek et al, 1996). In contrast to
desmosomes and hemidesmosomes, adherens junction-type contacts
are linked to cytoskeletal actin microfilaments rather than to
intermediate filaments (Green et al, 1987; Geiger and Ginsberg,
1991; Pavalko et al, 1991; Burge, 1994). As the ultrastructural
characteristics of adherens junctions are less prominent than those
of desmosomes, they have been described in epidermis only recently
(Kaiser et al, 1993a; Haftek et al, 1996). Desmosomes and adherens
junctions are closely located and their assembly is spatially and
temporally co-ordinated in vitro (Green et al, 1987). In fact, the
formation of adherens junctions has been suggested to be a
prerequisite for desmosome formation (Garrod et al, 1996).
The presence of adherens junctions connecting basal ker-
atinocytes and the underlying basement membrane has been
suggested on the basis of the detection of vinculin and talin in
dermal–epidermal junction (Kaiser et al, 1993a, b). In cell cultures,
these intracellular proteins are components of focal adhesions
connecting, e.g., keratinocytes and fibroblasts to the culture sub-
stratum. Focal adhesions are suggested to represent an attachment
device in cell cultures corresponding to cell–extracellular matrix
adhesions in vivo (Burridge et al, 1988; Burridge and Fath, 1989;
Jockusch et al, 1995). Junctions containing vinculin and talin have
previously been detected in, e.g., dense plaques of smooth muscle
cells and myotendinous junctions of skeletal muscle (Geiger et al,
1985; Burridge et al, 1988).
Transmembrane components of adherens junctions include
E-cadherin which participates in cell–cell junctions only (Wheelock
and Jensen, 1992; Haftek et al, 1996), and β1 integrins which are
expressed by the basal keratinocytes both in the cell–cell and the
cell–matrix contacts (Peltonen et al, 1989; Larjava et al, 1990).
Correspondingly, transmembrane components of hemidesmosomes
include a member of integrin family, namely α6β4 integrin, and a
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collagenous transmembrane protein, BP180/BPAG2, or type XVII
collagen (Ryyna¨nen et al, 1991; Borradori and Sonnenberg, 1996;
Uitto and Pulkkinen, 1996).
Type XIII collagen is a ubiquitously expressed transmembrane
protein which has three extracellular collagenous domains (COL1–
COL3) separated by noncollagenous domains NC2 and NC3
(Pihlajaniemi et al, 1987; Pihlajaniemi and Tamminen, 1990). The
extreme amino-terminal noncollagenous domain, NC1, consists
of a 40 residue-long intracellular domain and a hydrophobic
transmembrane sequence (Ha¨gg et al, 1998). The C-terminal end
is formed by the noncollagenous domain NC4. The total length
of the α1(XIII) collagen chain is affected by complex alternative
splicing of the α1(XIII) collagen RNA (Juvonen and Pihlajaniemi,
1992; Juvonen et al, 1992). In humans, a total of 10 exons encoding
both collagenous and noncollagenous sequences can be alternatively
spliced. α1(XIII) collagen mRNA has been found by reverse
transcription combined with polymerase chain reaction (PCR), or
by in situ hybridization techniques in various tissues, such as skin,
skeletal and heart muscles, tendon, kidney, liver, spleen, intestine,
brain, peripheral nerve and placenta (Sandberg et al, 1989; Juvonen
et al, 1993; Peltonen et al, 1997). In developing skin, the expression
of α1(XIII) collagen mRNA has been localized to epidermis by
in situ hybridization (Sandberg et al, 1989). Studies at the protein
level revealing cellular localization of type XIII collagen in these
tissues have not been available until recently (Ha¨gg, 1998) and thus
the function of type XIII collagen has been unknown. Recent
studies at the protein level, however, have demonstrated type XIII
collagen epitopes at the periphery of HT 1080 cells where it co-
localized with β3 integrin epitopes (Ha¨gg et al, 1998). In skin
fibroblasts, the immunosignal is located peripherally and co-local-
ized with vinculin and talin suggesting association with focal
contacts (Ha¨gg, 1998).
In this study, epidermis and cultured keratinocytes were investi-
gated to elucidate the potential functions of type XIII collagen.
Reverse transcription and PCR techniques and western blotting
were utilized to study the expression of type XIII collagen in
epidermis and in cultured keratinocytes. Double immunolabeling
technique was used to localize type XIII collagen, vinculin,
E-cadherin, α-catenin, desmoglein, and desmoplakin in normal
epidermis and cultured keratinocytes. These studies localized type
XIII collagen to cell–cell and cell–matrix contacts.
MATERIALS AND METHODS
Tissue samples and cell culture Skin samples were obtained from
plastic surgical operations carried out for cosmetic reasons from 10 healthy
persons (aged 20–67 y) at the Turku University Hospital, Finland. These
samples were used for keratinocyte cultures, indirect immunofluorescence
(IIF), RNA isolation, and western blotting. Three samples of fetal skin,
gestational weeks 15–17, were obtained from the Department of Obstetrics
and Gynecology, University of Turku, Finland. Primary cultures of normal
human keratinocytes were established from adult skin samples by a
modification of the method of Boyce and Ham (1985). Keratinocytes were
maintained in serum-free low calcium keratinocyte growth medium
(Clonetics, San Diego, CA). For experimentation, primary or first passage
keratinocytes were passaged by trypsinization and grown until about
40% confluency in medium which contains low, 0.15 mM, calcium
concentration. Two identical groups of culture flasks were seeded, and the
medium was changed either to the low calcium medium or to the medium
containing 1.4 mM Ca21. Cells were harvested for western blotting after
0, 4, and 24 h incubation. In addition, 15 min, 30 min, and 24 h
incubations were used for IIF.
IIF labeling Frozen sections of normal skin were cut on silanated glass
slides and keratinocytes were grown on glass coverslips. Samples were fixed
with 100% methyl alcohol at –20°C for 10 min. To prevent nonspecific
binding, the samples were preincubated in phosphate-buffered saline (PBS)
supplemented with 1% bovine serum albumin (BSA) for 15 min. The
primary antibodies were diluted in 1% BSA–PBS, and incubated on the
samples at 4°C for 20 h. Following five 10 min washes in PBS, the slides
were incubated with secondary antibodies (see below) at 20°C for 1 h.
After the incubation the samples were washed five times in PBS and
mounted with Glycergel (Dako, Glostrup, Denmark). Control immunore-
actions included the following: (i) primary antibody was replaced with 1%
BSA–PBS; (ii) primary antibody was replaced with preimmune rabbit sera
diluted 1:50 in 1% BSA–PBS; or (iii) primary antibody was preabsorbed
with 10 M excess of synthetic peptide, which was originally used for
immunization. In addition, secondary and primary antibodies used in
double labelings were tested for cross-reactions. In all controls described
above, only a faint uniform background fluorescence was observed.
Confocal laser scanning microscopy (CLSM) This was carried out
using Leica TCS SP Spectral Confocal Microscope (Heidelberg/Wetzlar,
Germany) with an air-cooled argon/krypton ion-laser system
(Omnichrome, Chino, CA), and Leica TCS NT software (Version 1.6.551
Heidelberg, Germany). The objective magnification used was 63 3 (oil
immersion, numeric aperture 5 1.40), or 100 3 (oil immersion, numeric
aperture 1.40–0.7). Emission light was focused through a pinhole aperture
having a diameter ratio of 50, and the optical sections averaged eight times
in square image formats of 1024 3 1024 or 256 3 256 pixels. Final images
were saved as tagged image file format and printed directly with a photo
printer with a resolution of 300 d.p.i.
When the separately acquired red and green channels of confocal images
are merged together the overlapping red and green pixels are additively
mixed and displayed in yellow. The colocalization of the signals was
quantitated from the 24 bit real color images with an image analysis system
MCID M4 (ver. 3.0, rev. 1.1, Imaging Research, St Catharines, Canada)
by determining the percentile areas of red, green, and yellow pixels over
the plasma membranes.
Antibodies The following antibodies were used: for type XIII collagen
a rabbit polyclonal antibody against a synthetic peptide corresponding to
the NC3 domain (Ha¨gg et al, 1998), and a rabbit polyclonal antibody
against a recombinant protein corresponding to intra- and extracellular
parts of the NC1 domain (Ha¨gg et al manuscript); mouse monoclonal
antibodies to human vinculin (MCA465S, Serotec, Kidlington, Oxford,
U.K.); human E-cadherin (13–1700 Zymed, S. San Francisco, CA); human
desmoplakin I and II (881 147, Boehringer Mannheim Biochemica,
Mannheim, Germany); human α-catenin (C21620) and desmoglein 1,
amino acids 705–1029, of intracellular domain (D28120), both from
Transduction Laboratories (Lexington, KY). Swine anti-rabbit (R056) or
rabbit anti-mouse (R270) IgG (both from Dako) were used as secondary
antibodies. In double labelings, tetramethyl-rhodamine isothiocyanate con-
jugated swine anti-rabbit IgG was mixed with fluorescein isothiocyanate
conjugated F(abc)2 fragment of goat anti-mouse immunoglobulins
(F0479, Dako).
Isolation of RNA RNA was isolated from cultured keratinocytes by acid
guanidinium isothiocyanate–chloroform–phenol extraction (Chomczynski
and Sacchi, 1987), and from adult and fetal skin using RNAzol B kit
(CS-105, TEL-Test, Friendswood, TX), according to the protocol provided
by the manufacturer. To obtain RNA from epidermal keratinocytes, the
epidermal aspect of fresh, 2 3 2 cm pieces of skin from three normal
adults were gently scraped with a scalpel and RNA was isolated from
detaching cells using RNAzol B kit. Prior to use in the reverse transcription
reactions, the RNA preparations were evaluated by running on agarose
gel, and were found to be intact.
Reverse transcription and PCR In reverse transcription reactions,
3 µg of the total RNA was transcribed into single-stranded DNA in a
20 µl reaction containing first-strand buffer (250 mM Tris–HCl, pH 8.3,
375 mM KCl, 15 mM MgCl2), 10 mM dithiothreitol, 0.5 mM of each of
the four deoxynucleotides, 100 pmol of Random Primer (Promega,
Madison, WI) 20 U of rRNasin (Promega), and 100 U of MLV reverse
transcriptase (GIBCO, Grand Island NY). The reaction was incubated for
60 min at 37°C. One microliter of the reverse transcription reaction
product was used as a template in a 10 µl reaction containing 20 pmol of
α1(XIII)-specific sense and anti-sense oligonucleotide primers (see below),
0.2 mM of each of the four deoxynucleotides and 1 U of Dynazyme (from
Thermus brockianus, strain F 500, Finnzymes, Espoo, Finland) in a buffer
with 10 mM Tris–HCl, pH 8.8, 50 mM KCl, 2.5 mM MgCl2 and 0.1%
Triton X-100. Amplification was performed by incubating the mixture for
30 cycles of denaturation (60 s at 94°C), annealing (60 s at 65°C) and
extension (60 s at 72°C). In the negative control samples the template was
omitted and PCR was performed under the same conditions as elsewhere.
The PCR products were analyzed electrophoretically on 4% agarose gels
(3% low gelling agarose Sigma, St Louis, MO, and 1% SeaKem GTG
agarose, FMC Bio Products, Rockland, ME). The following oligonucleot-
ides with EcoRI or BamH1 restriction sites (underlined) were used as
primers for the PCR reactions: A, 59 AAGGATCCTGGACGAGAAATG-
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GAAGCTCC 39 (nt 158–179 in Pihlajaniemi and Tamminen, 1990); B,
59 TTGAATTCGTGTGGGTACTCTCCACACTGACC 39 (nt 503–
526); C, 59 TTGGATCCGGTCAACCAGGCACTAGAGGTTTCC 39
(nt 359–383), and D, 59 TTGAATTCTTGGATGCTGGCCTGGCTCT-
GTTCG 39 (nt 589–614).
Western blotting Normal human keratinocytes were cultured in
conditions described above. For western blotting the cells were
washed with PBS and lysed in solution containing 62.5 mM Tris–
HCl, pH 6,8; 2.3% sodium dodecyl sulfate, and 8% glycerol. The
concentrations of the protein samples were measured with DC
Protein Assay Kit provided by Bio-Rad (Richmond, CA). The
culture media were centrifuged to remove detached cells and
proteins were precipitated with 70% ethanol and centrifuged at
13 8003 g for 20 min. The pellets were dried and diluted in sample
buffer (15 mM Tris, pH 6.8; 2.5% glycerol, 0.5% sodium dodecyl
sulfate, 0.003% bromophenol blue) and the samples were reduced
with 2-mercaptoethanol at 100°C for 3 min. To separate epidermis
from dermis a 2 3 2 cm piece of normal skin was heated at 56°C
for 30 s in PBS and the epidermis was detached with forceps
(Ohata et al, 1995). The epidermis was homogenized in cell lysis
solution (see above), centrifuged, and the supernatant was diluted
in sample loading buffer and reduced. The protein samples were
then applied to 4/10% sodium dodecyl sulfate–polyacrylamide gel
electrophoresis gels and electrophoresed at 200 V in a Bio-Rad
minigel apparatus until the dye front reached the bottom of the
gel. The proteins were electroblotted on to Immobilon P filters
(Millipore, Bedford, MA). To evaluate the even transfer of all
samples the filters were stained with heparin and toluidine. After
destaining and washing with Tris-buffered saline (TBS), the filters
were incubated in 3% BSA–TBS for 30 min. The primary antibody
for the NC3 domain was then applied to the filters at a dilution
of 1:100 in 3% BSA–TBS and incubated at 4°C overnight. The
filters were washed in TBS three times for 5 min and incubated
in horseradish-peroxidase-conjugated goat anti-rabbit secondary
antibody (Bio-Rad) diluted 1:10,000 in 3% BSA–TBS at 4°C for
112 h. Finally, the filters were washed in TBS three times for 5 min.
The bound peroxidase activity was detected using the enhanced
chemiluminescence substrate as recommended by the manufacturer
(Amersham International, Poole, U.K.), and Kodak-X-Omat film
(Kodak, Rochester, NY).
RESULTS
Type XIII collagen is localized to the epidermis in normal
human skin The spatial distribution of type XIII collagen in
normal adult human skin was studied by indirect immunofluores-
cence. For immunolabeling, two antibodies were used: (i) polyclonal
antibody raised against a synthetic peptide corresponding to the
sequence of the extracellular NC3 domain, and (ii) polyclonal
antibody against a recombinant protein covering sequences of both
the cytoplasmic and extracellular parts of the NC1 domain. Both
of these antibodies revealed a positive immunosignal for type
XIII collagen in epidermis apparently in association with plasma
membranes of keratinocytes (Fig 1). The lateral aspects of basal
keratinocytes, however, were less intensely labeled compared with
suprabasal layers within the same tissue sections (Fig 1a, b). Previous
studies have demonstrated that selected adhesion molecules such as
E-cadherin and catenins display variation in expression levels within
the basal layer of human epidermis (Moles and Watt, 1997). The
immunoreaction with the antibody for the NC3 domain was
particularly intense in the stratum granulosum (Fig 1a). High
magnification revealed that the labeling for type XIII collagen was
arranged in linear spots in the cell periphery (Fig 1c). This labeling
pattern highly resembled that of E-cadherin in epidermis (Fig 1d).
Both anti-type XIII collagen antibodies labeled the dermal–epi-
dermal junction, the immunoreaction for the NC1 domain being
particularly intense (Fig 1b). In addition to the positive immuno-
reaction in epidermis, type XIII collagen antibodies labeled strongly
blood vessel walls (Fig 1b) and cutaneous nerves (not shown).
Type XIII collagen displays high degree of colocalization
with E-cadherin As the immunoreaction for type XIII collagen
at the cell periphery resembled the labeling pattern of cell junctional
proteins, we utilized double immunolabelings to search for potential
colocalization of type XIII collagen with previously characterized
cell adhesion molecules. First, double immunolabelings with anti-
bodies to type XIII collagen and to desmosomal components,
desmoglein and desmoplakin, were carried out (Fig 2). CLSM
analysis of the tissue samples revealed rather little colocalization of
type XIII collagen with desmoplakin and desmoglein. In fact, high
magnification revealed that the spatial distribution of type XIII
collagen and desmosomal markers often displayed a mutually
exclusive labeling pattern (Fig 2c, d). Of adherens junction proteins,
E-cadherin appeared to display highest degree of colocalization
with the NC1 domain of type XIII collagen in the cell–cell contacts
(Fig 3a). In order to analyze the colocalization of desmoplakin and
type XIII collagen, as well as E-cadherin and type XIII collagen
in more detail, quantitation of the proportional areas of labels was
done from the 24-bit real color images. The results revealed that
desmoplakin and type XIII collagen co-localized in only 8.7% of
the pixels in the cell membrane area. This area covered most of
the epidermal cell borders excluding the basement membrane zone
in Fig 2(a). Corresponding analysis of double labeling for type
XIII collagen and E-cadherin was carried out using Fig 3(a).
E-cadherin and type XIII collagen co-localized in 43.9% of the
total cell membrane area. Compared with E-cadherin, vinculin and
α-catenin displayed less complete colocalization with type XIII
collagen in intercellular junctions (Fig 3b, c, f, g). Furthermore,
vinculin and type XIII collagen labeled the dermal–epidermal
junction (Fig 3b). The immunoreaction for type XIII collagen,
however, was clearly broader than the reaction for vinculin on this
location. To conclude, these results suggest that type XIII collagen
has closer spatial connection with components of adherens junctions
compared with the components of desmosomes.
Type XIII collagen is localized to cell–matrix and cell–cell
contacts in cultured keratinocytes The regulation of type
XIII collagen expression was studied in cultured keratinocytes.
Normal human keratinocytes cultured in low (0.15 mM) calcium
concentration grow as a monolayer, remain undifferentiated, and
form only a low number of intercellular junctions (O’Keefe et al,
1987). In this study, keratinocytes plated on glass substratum in
low-calcium concentration initially expressed type XIII collagen as
intensely labeled spots apparently representative of cytoplasmic
vacuoles (Fig 4a). In a few hours, immunoreaction for type XIII
collagen could be visualized as bright short streaks at the periphery
of the cells (Fig 4b). As this pattern resembled that of focal contacts,
double labelings for type XIII collagen and for vinculin and talin
were carried out. These labelings revealed colocalization of type
XIII collagen with vinculin and talin at the cell periphery (Fig 5a,
b) suggesting that type XIII collagen was associated with focal
contacts of cultured keratinocytes.
When keratinocytes are maintained in high calcium concentra-
tion the cells gather in groups in which they form intercellular
contacts and start to stratify. In groups of keratinocytes, focal
contacts are maintained only by cells which are located at the
periphery of the cell group (O’Keefe et al, 1987). In this study,
type XIII collagen was expressed in the focal contacts located at
the periphery of the keratinocyte groups (Fig 4c). Type XIII
collagen epitopes accumulated also in a linear manner at intercellular
contacts of keratinocytes maintained in high-calcium concentration
(Fig 4c). The distribution of type XIII collagen epitopes to the
cell–cell contacts was rapid after the low calcium medium was
changed to high calcium medium: type XIII collagen was located
in cell–cell contacts as early as within 15 min. Correspondingly,
vinculin is known to redistribute to the cell–cell borders shortly
after elevation of the calcium concentration (O’Keefe et al, 1987;
Wheelock and Jensen, 1992). In double immunolabelings, type XIII
collagen revealed almost complete colocalization with E-cadherin
(Fig 6a) and α-catenin (Fig 6c), especially in the cell–cell borders
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Figure 1. Type XIII collagen is expressed at cell–cell and cell-basement membrane contact sites in normal human epidermis. Frozen
sections of human skin were subjected to IIF with polyclonal antibodies to the NC1 and NC3 domains of type XIII collagen and analyzed using
conventional microscopy (a) or CLSM (b–d). (a) The antibody against the NC3 domain revealed a positive immunoreaction at the periphery of
keratinocytes of all epidermal layers and at dermal–epidermal junction. (b) The antibody to the NC1 domain revealed an essentially similar labeling pattern
as the NC3 antibody, with the exception that the dermal–epidermal junction was more intensely labeled with the NC1 domain-specific antibody. (c)
High magnification showed that the labeling pattern for the NC1 domain was patchy and organized in a linear manner, apparently in association with
plasma membrane. (d) E-cadherin labeling of the epidermis resembled that of the NC1 domain of type XIII collagen. Scale bars: (a, b) 10 µm; (c, d) 5 µm.
Figure 2. Double immunolabeling suggests distinct subcellular locations for type XIII collagen and desmosomal proteins in epidermis.
Double immunofluorescence labelings of the same 0.5 µm optical sections were analyzed with CLSM. (a, c, d), type XIII collagen and desmoplakin; (b,
e) type XIII collagen and desmoglein. Red represents type XIII collagen and green desmosomal antigens. In low magnification, yellow color represents
either colocalization or close spatial association of these antigens, the signals of which were somewhat mixed in low magnification frames a and b. A
computer-assisted analysis of the pixels covering the epidermis in frame a, however, revealed only 8.7% colocalization of the immunosignals representative
of type XIII collagen and desmoplakin (for details, see text). (c) A randomly selected field taken with high original magnification and (d) an enlarged area
pointed by an arrow in (a) reveal that the distribution of type XIII collagen and desmoplakin was often mutually exclusive. (b, e) Double immunolabeling
with type XIII collagen and desmoglein antibodies also showed only little colocalization. Scale bars: (a, b) 10 mm; (c, e) 2 µm; (d) 1 µm.
whereas vinculin and type XIII collagen showed a partial colocaliz-
ation at the intercellular contacts (Fig 6b).
Desmosomes have been demonstrated to be located closer to
the cell culture substratum than adherens junctions (O’Keefe et al,
1987). In this study, double immunolabeling of keratinocytes for
type XIII collagen and desmoplakin localized desmoplakin epitopes
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Figure 3. Type XIII collagen and components of adherens junctions, E-cadherin, vinculin, and a-catenin co-localize in epidermis. Double
immunofluorescence labelings of the same 0.5 µm optical sections were analyzed with CLSM. (a, d, e) Type XIII collagen and E-cadherin; (b, f) type
XIII collagen and vinculin; (c, g) type XIII collagen and α-catenin. Red demonstrates type XIII collagen and green adherens junction proteins. A
computer-assisted analysis of the pixels covering the epidermis in frame a demonstrated 43.9% colocalization of the immunosignals representative of type
XIII collagen and E-cadherin above the basement membrane zone (for details, see text). (d) A randomly selected field taken with high original
magnification, and (e) an enlarged area pointed by an arrow in figure a reveal marked colocalization of type XIII collagen and E-cadherin in a patchy
linear manner, apparently in close association with plasma membrane. (b, f) Double labeling for type XIII collagen and vinculin revealed partial
colocalization in the cell–cell contact sites and in the dermal–epidermal junction. (c, g) Type XIII collagen and α-catenin showed partial colocalization in
the cell–cell contact sites. Scale bars: (a–c) 10 µm; (d, f, g) 2 µm; (e) 1 µm.
Figure 4. Type XIII collagen is targeted to different subcellular locations in keratinocytes under different culture conditions. (a) Type XIII
collagen was located to bright intracellular spots shortly after plating keratinocytes on culture substratum as visualized by IIF and subsequent CLSM
analysis. (b) Keratinocytes cultured in low calcium concentration expressed type XIII collagen peripherally in short streaks (arrows). (c) Keratinocytes
maintained in high calcium concentration revealed type XIII collagen epitopes in cell–cell contacts as well as in the focal contacts of the cells located in
the periphery of the cell groups (arrow). Antibody to NC3 in (a) and (b); antibody to NC1 in (c). Scale bars: (a) 5 µm; (b) 10 µm; (c) 20 µm.
closer to the culture substratum, whereas type XIII collagen was
present only at a higher level in cell–cell borders as evaluated by
CLSM (Fig 7), further suggesting that type XIII collagen is not a
desmosomal component. In summary, our cell culture results
demonstrate that type XIII collagen is targeted to different subcellu-
lar locations in keratinocytes under different culture conditions.
Colocalization of type XIII collagen with vinculin and talin in
focal contacts, and with E-cadherin and α-catenin in cell–cell
contacts, strongly suggest association of type XIII collagen with
components of adherens type junctions in cultured keratinocytes.
Western blotting detects type XIII collagen in epidermis,
cultured keratinocytes, and cell culture medium Samples of
cell lysate from keratinocytes with culture periods of 0, 4, or 24 h
in high or low calcium concentration were subjected to western
blotting using the antibody for the NC3 domain of type XIII
collagen. These analyses revealed the presence of a 105–110 kDa
band in all samples (Fig 8A). Incubation of the antibody with 10
times molar excess of the peptide used for immunization completely
abolished these bands. To investigate whether type XIII collagen
is released in low or high calcium culture medium, secreted proteins
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of the 4 and 24 h culture periods were precipitated with ethanol
and subjected to western blotting (Fig 8B). The 4 h protein samples
revealed type XIII collagen as barely detectable broad bands with
relative molecular mass of 90–110 kDa whereas the corresponding
protein bands at the 24 h were more prominent. These results
suggest that the extracellular part of type XIII collagen is cleaved,
and that the extracellular part is released into the culture medium.
Western transfer analysis of the epidermal preparation visualized a
type XIII collagen band with identical mobility compared with
that obtained from cultured keratinocytes (Fig 8B).
Reverse transcription–PCR demonstrates a1(XIII) collagen
mRNA in human skin Samples of adult and fetal whole skin
Figure 5. Type XIII collagen co-localizes with vinculin and talin
in focal adhesions of cultured keratinocytes maintained in low-
calcium concentration. Double immunofluorescence labelings of
cultured keratinocytes were analyzed with CLSM. (a) Keratinocytes
cultured in low-calcium concentration were labeled for the NC3 domain
of type XIII collagen (red) and vinculin (green). CLSM analysis showed
colocalization (yellow) in the focal contacts. (b) Also talin co-localized with
type XIII collagen in focal contacts. Scale bars: 5 µm.
Figure 6. Type XIII collagen, E-cadherin, vinculin, and a-catenin co-localize in cell–cell contacts of cultured keratinocytes. (a) CLSM
visualization of the basal surface of keratinocytes cultured in high-calcium medium revealed marked colocalization (yellow) of type XIII collagen (red) and
E-cadherin (green) at the cell–cell borders. (b) Type XIII collagen and vinculin showed partial colocalization in cell–cell contacts. (c) Type XIII collagen
and α-catenin co-localized also in keratinocyte cell–cell borders. Scale bars: (a, b) 10 µm; (c) 5 µm.
and adult epidermal specimens were analyzed using two pairs of
oligonucleotide primers: one corresponded to the sequences for
the COL1 region, and the other to the NC2 sequences. PCR
amplification revealed type XIII collagen mRNA in adult and fetal
skin, and in epidermis dissected from adult skin (Fig 8C). Because
of the alternative splicing of type XIII collagen RNA, the reverse
transcription-PCR yielded several DNA fragments. Analysis of the
COL1 region revealed six DNA fragments which represent mRNA
variants with different combinations of sequences encoded by exons
3B, 4A, 4B, and 5 (Fig 8C) (Juvonen and Pihlajaniemi, 1992;
Juvonen et al, 1992). Analysis of the NC2 domain revealed
two DNA fragments corresponding to the variants generated by
alternative splicing of the exon 12 and 13 sequences.
DISCUSSION
The results of this study localized type XIII collagen to the dermal–
epidermal junction and to the periphery of keratinocytes in all
epidermal layers identifying type XIII collagen as a potential
cell adhesion molecule. Double immunolabelings with antibodies
specific to type XIII collagen and components of desmosomes
(such as desmoplakin and desmoglein), and adherens junctions
(such as E-cadherin, vinculin, and α-catenin), were utilized to
characterize further the localization of type XIII collagen in
epidermis. These studies revealed that: (i) type XIII collagen is not
merely a diffusely distributed membrane protein; (ii) desmoplakin
and type XIII collagen displayed very little colocalization in the
epidermis suggesting that type XIII collagen is unlikely to be a
component of desmosomes; and (iii) type XIII collagen showed
marked colocalization with proteins of adherens junctions.
Specifically, a high degree of colocalization of type XIII collagen
and E-cadherin was noted at the cell–cell contact sites but not at the
dermal–epidermal junction: 43.9% of the pixels on all membranes in
the CLSM image showed colocalization in epidermis. Vinculin and
α-catenin showed a less complete colocalization with type XIII
collagen in intercellular junctions. As described earlier (Moles and
Watt, 1997) α-catenin was not detected at the dermal–epidermal
junction, whereas vinculin was easily detectable in this location.
Double labelings with antibodies to vinculin and type XIII collagen
showed that even though both of these proteins were localized to
the dermal–epidermal junction their labeling patterns were not
quite identical. Specifically, the antibody to the NC1 domain of
type XIII collagen, but not the antibody to the NC3 domain,
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displayed a markedly broader immunosignal compared with vincu-
lin. At present we do not have an explanation for this finding.
The expression of type XIII collagen by keratinocytes was further
studied in cell cultures maintained in low calcium concentration,
which allows the cells to maintain their basal phenotype, and in
high calcium concentration, which promotes the differentiation of
keratinocytes and induces the formation of intercellular junctions.
Cultured keratinocytes revealed a positive immunoreaction for type
XIII collagen in three different locations. (i) Within a few minutes
Figure 7. Double immunolabeling suggests distinct subcellular locations for type XIII collagen and desmosomal proteins in cultured
keratinocytes. Double immunofluorescence labeling for the NC1 domain of type XIII collagen and desmoplakin. Parts (a) and (b) show a 0.5 µm optic
section close to the basal surface of the cultured keratinocytes. CLSM revealed desmoplakin (a) but not type XIII collagen (b) in the cell–cell contacts.
Parts (c) (desmoplakin) and (d) (type XIII collagen) show a 0.5 µm optic section 1.5 µm more apically compared with panels (a) and (b). Part (e) shows
a combination picture of an enlarged area indicated by an arrow in frames (c) and (d); immunolocalization of type XIII collagen is shown by red, and
desmoplakin by green. Scale bars: (a–d) 20 µm; (e) 1 µm.
Figure 8. Western blotting and reverse transcription-PCR demonstrate type XIII collagen protein and mRNA in cultured keratinocytes
and epidermis. (A) Western blotting of keratinocyte lysates with antibody to the NC3 domain of type XIII collagen revealed a broad band with a size
of 105–110 kDa. Lane 1, keratinocytes maintained in low calcium concentration at time-point 0 h. Lanes 2 and 4, cells cultured in low calcium
concentration for 4 and 24 h, respectively. Lanes 3 and 5, cultures in high calcium concentration for 4 and 24 h, respectively. (B) Western blotting of
proteins precipitated from keratinocyte culture medium (lanes 6–9). Samples were taken after 4 h incubation in low calcium medium (lane 6) or high
calcium medium (lane 7). 24 h cultures in low (lane 8) and high calcium concentration (lane 9). Lane 10, sample from epidermis was prepared by heat
separation. (C) Total RNA was isolated from adult and fetal skin and epidermis. Single-stranded cDNA was synthesized by reverse transcriptase and PCR
was performed as described in Materials and Methods. The panel shows amplification products of the reverse transcription-PCR reactions fractionated on
4% agarose gels and stained with ethidium bromide. Two left lanes represent adult whole skin samples, two middle lanes epidermal and two right lanes
fetal skin samples. Each cDNA was amplified using oligonucleotide primer pairs for either the COL1 sequences or NC2 sequences. PCR amplification
of the COL1 sequences revealed six DNA fragments representing type XIII collagen mRNA sequences. The identification was based on the migration
position of the bands and previous characterization of the splice variants by DNA sequencing. The sizes in nucleotides and splice variants of the exons
3B, 4A, 4B, and 5 are indicated on the left and those of the exons 12 and 13 are shown on the right.
after plating the keratinocytes spread and expressed type XIII
collagen as intracellular patches. (ii) When the cells were further
cultured in low calcium concentration, keratinocytes expressed
type XIII collagen in focal contacts connecting cells to the cell
culture substrate. (iii) The induction of keratinocyte differentiation
by the elevated calcium concentration of the culture medium was
associated with the appearance of positive immunoreaction for type
XIII collagen in the cell–cell contact sites. This suggested that type
XIII collagen has a very similar dynamics as some well established
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cell junction components, e.g., vinculin and E-cadherin, which are
deposited intracellularly and transferred to their functional sites
(O’Keefe et al, 1987; Wheelock and Jensen, 1992). In cultured
keratinocytes, immunoreaction for desmoplakin was detected closer
to the culture substratum, type XIII collagen labeling being
detectable at a higher plane in the CLSM analysis. This finding is
in line with a previous ultrastructural report showing adherens
junctions at a higher level compared with desmosomes, which are
present closer to the basal surface of keratinocytes (O’Keefe et al,
1987). The colocalization of type XIII collagen with talin and
vinculin in the focal contacts of cultured keratinocytes suggests that
type XIII collagen may be associated with these contacts. Although
the intermolecular interactions of type XIII collagen with other
transmembrane molecules are not known, the apparent colocaliz-
ation of type XIII collagen with adherens junction proteins on
many, but not all locations, suggests that type XIII collagen may
be a component of adherens junctions and may play a part in cell
adhesion between keratinocytes. Defining the precise relationship
between type XIII collagen and adherens junctions will require
the use of biochemical and higher resolution techniques. Based on
these results one can speculate that a mutation affecting the structure
of type XIII collagen might cause weakness in cell–cell adhesion
leading to diminished mechanical strength of epidermis. We also
speculate that in analogy to certain other epidermal transmembrane
proteins, such as BPAG2, mutations to type XIII collagen gene
may play a part in pathogenesis of selected epidermal diseases.
Specifically, one could expect blistering suprabasally and/or at the
junctional level. In addition, autoantibodies targeted to type XIII
collagen might be detected in certain cases of blistering diseases
based on autoimmune reaction.
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